DERM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Journey Medical Corp (DERM) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The technical indicators suggest a bearish trend, options data indicates a lack of bullish sentiment, and financial performance shows declining profitability despite revenue growth. With no significant positive catalysts or recent news, holding off on investment is recommended until clearer positive signals emerge.
The MACD is negative and expanding downward (-0.104), indicating bearish momentum. RSI is at 22.97, suggesting the stock is oversold but not providing a clear buy signal. Moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 7.683), with resistance at 8.714. Overall, technicals indicate a bearish trend.
Revenue increased by 20.52% YoY in Q3 2025, which indicates some growth in the top line.
and a low probability of short-term gains based on candlestick analysis.
In Q3 2025, revenue grew by 20.52% YoY to $17.63M, but net income dropped to -$2.315M (-3.14% YoY). EPS declined to -0.09 (-25.00% YoY), and gross margin fell to 61.32% (-3.99% YoY). Overall, financial performance shows growth in revenue but declining profitability.
No analyst rating or price target data available.
